Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis

BACKGROUND: Most patients with chronic obstructive pulmonary disease (COPD) receive inhaled long-acting bronchodilators and inhaled corticosteroids. Conventional meta-analyses established that these drugs reduce COPD exacerbations when separately compared with placebo. However, there are relatively...

Descripción completa

Detalles Bibliográficos
Autores principales: Puhan, Milo A, Bachmann, Lucas M, Kleijnen, Jos, ter Riet, Gerben, Kessels, Alphons G
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2636836/
https://www.ncbi.nlm.nih.gov/pubmed/19144173
http://dx.doi.org/10.1186/1741-7015-7-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2636836/
https://www.ncbi.nlm.nih.gov/pubmed/19144173
http://dx.doi.org/10.1186/1741-7015-7-2

Ejemplares similares